A Phase 1b study of E-CEL UVEC cells in chronic anal fissures
Recruiting Phase 1 NCT06456073
Study Description
An early study to evaluate the safety and potential benefits of E-CEL UVEC cell injections for healing chronic anal fissures
Study Details
- Registry ID:
- NCT06456073
- Conditions:
- Chronic Anal Fissure
- Phase:
- Phase 1
- Target Enrollment:
- 20 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (2 sites)
-
Weill Cornell Medicine
New York, New York, United States -
Weill Cornell Medicine
New York City, New York, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.